Back

Imaging to define cardiac amyloidosis prognosis: practical implications.

9 December 2021 (14:30 - 14:40)
Organised by:
Congress Presentation Part of: Management of cardiac amyloid guided by multimodality imaging: the paradigm has shifted Cross-Modality and Multi-Modality Imaging Topics, Other EACVI Premium Access EuroEcho 2021

About the speaker

Photo
Doctor Sharmila Dorbala

Brigham and Women's Hospital, Boston (United States of America)

3 More presentations in this session

Presentation thumbnail
From clinical to multimodality imaging: red flags in cardiac amyloidosis diagnosis.
Doctor P. Soman (Pittsburgh, US)
Slides Video
Presentation thumbnail
Imaging endpoints in cardiac amyloidosis therapy: current state and future outlook.
Professor M. Fontana (London, GB)
Slides Video
Presentation thumbnail
Management of cardiac amyloid guided by multimodality imaging: the paradigm has shifted - discussion.
Video

Access the full session

Session thumbnail
Management of cardiac amyloid guided by multimodality imaging: the paradigm has shifted
Video

The Event

Event poster

EuroEcho 2021

9 December 2021 14:30 CET
You may be interested in
thumbnail
Webinar
Diagnosing and treating cardiac amyloidosis
17 November 2022
thumbnail
Congress Presentation
Prognostic impact of left atrial function in patients with cardiac amyloidosis: a cardiac magnetic resonance study
1 September 2019
thumbnail
Congress Presentation
Prognostication of cardiac amyloidosis by pittsburgh b compound positron emission tomography
28 August 2020
thumbnail
Congress Presentation
Clinical and imaging features of cardiac amyloidosis in Saudi Arabia
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources